Skip to main content

A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects

Clinical Trial Grant
Duke Scholars

Awarded By

Gilead Sciences, Inc.

Start Date

April 17, 2016

End Date

June 27, 2019
 

Awarded By

Gilead Sciences, Inc.

Start Date

April 17, 2016

End Date

June 27, 2019